These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 7745428)
1. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. Smith TW; Lippa CF J Neuropathol Exp Neurol; 1995 May; 54(3):297-303. PubMed ID: 7745428 [TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration. Dickson DW; Feany MB; Yen SH; Mattiace LA; Davies P J Neural Transm Suppl; 1996; 47():31-46. PubMed ID: 8841955 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790 [TBL] [Abstract][Full Text] [Related]
4. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450 [TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Bussière T; Hof PR; Mailliot C; Brown CD; Caillet-Boudin ML; Perl DP; Buée L; Delacourte A Acta Neuropathol; 1999 Mar; 97(3):221-30. PubMed ID: 10090668 [TBL] [Abstract][Full Text] [Related]
7. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792 [TBL] [Abstract][Full Text] [Related]
8. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342 [TBL] [Abstract][Full Text] [Related]
9. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. Joachim CL; Morris JH; Kosik KS; Selkoe DJ Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585 [TBL] [Abstract][Full Text] [Related]
10. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Schwab C; DeMaggio AJ; Ghoshal N; Binder LI; Kuret J; McGeer PL Neurobiol Aging; 2000; 21(4):503-10. PubMed ID: 10924763 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
12. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies. Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E Acta Neuropathol Commun; 2019 Dec; 7(1):195. PubMed ID: 31796108 [TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122 [TBL] [Abstract][Full Text] [Related]
14. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease. Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707 [TBL] [Abstract][Full Text] [Related]
15. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387 [TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles. Bancher C; Lassmann H; Budka H; Grundke-Iqbal I; Iqbal K; Wiche G; Seitelberger F; Wisniewski HM Acta Neuropathol; 1987; 74(1):39-46. PubMed ID: 2444063 [TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease. Masliah E; Mallory M; Alford M; Hansen LA; Saitoh T Lab Invest; 1993 Nov; 69(5):562-9. PubMed ID: 8246448 [TBL] [Abstract][Full Text] [Related]
18. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Vingtdeux V; Davies P; Dickson DW; Marambaud P Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Blanco R; Carmona M; Puig B Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions. de la Monte SM; Wands JR J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]